MARKET

RHHBY

RHHBY

Roche Hldg
OTCQX
56.37
-0.50
-0.88%
Closed 15:59 08/27 EDT
OPEN
56.59
PREV CLOSE
56.87
HIGH
56.64
LOW
56.22
VOLUME
168.00K
TURNOVER
9.49M
52 WEEK HIGH
59.03
52 WEEK LOW
38.32
MARKET CAP
311.20B
P/E (TTM)
23.78
1D
5D
1M
3M
1Y
5Y
1D
Roche gains expanded use of diagnostic tests to identify eligible Ziihera patients
Seeking Alpha · 1d ago
Roche receives FDA approval for companion diagnostic tests for Ziihera
TipRanks · 1d ago
Eli Lilly Stock (LLY) in Focus as Alzheimer Blood Test Gets FDA Approval
TipRanks · 1d ago
TG Therapeutics: Briumvi's Peak May Be Far Away (Rating Upgrade)
Seeking Alpha · 1d ago
Vanguard Dividend ETFs Comparison: VYMI vs. VIG vs. VYM for Income Investors
TipRanks · 2d ago
Genentech in up to $2.3B deal with Hanmi for novel weight loss drug
Seeking Alpha · 2d ago
Regeneron: Why I Still See Upside After The Rally
Seeking Alpha · 2d ago
Eli Lilly Stock (LLY) Gains on FDA Approval for Alzheimer’s Blood Test Developed with Roche
TipRanks · 3d ago
More
About RHHBY
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Webull offers Roche Holding AG (ADR) stock information, including OTCQX: RHHBY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RHHBY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RHHBY stock methods without spending real money on the virtual paper trading platform.